Inflation Reduction Act

0

Global Planning to Local Execution Market Success

Posted on by Grammati Sarri and Radek Wasiak

Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations and the role of automation. The worldwide drug regulation landscape is rapidly changing. The introduction of the EU health technology assessment… Continue Reading →

0

Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA

Posted on by Michael Broder

  The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to price negotiation under the Inflation Reduction Act of 2023 (IRA) and the Act’s potential impact on profits. But an even bigger force… Continue Reading →